RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. (IST:RTALB)

Market Cap	1.72B +19.0%
Revenue (ttm)	253.76M +9.7%
Net Income	301.56M +82.7%
EPS	0.60 +82.7%
Shares Out	500.00M
PE Ratio	5.70
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	19,943,720
Open	3.470
Previous Close	3.460
Day's Range	3.410 - 3.470
52-Week Range	2.860 - 5.080
Beta	0.40
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 7, 2026

About IST:RTALB

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. engages in the research, development, and production of microbiology and molecular biology products in Turkey. It offers real-time PCR kits, nucleic acid extraction kits, microbiology media, microbiology stains, and rapid tests; standards and reference materials, and membrane filters; chemicals and reactives, membrane filters, microbiology gas generators, and other consumables; and instruments and consumables. RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Tic...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1996
• Employees: 77
• Stock Exchange: Istanbul Stock Exchange
• Ticker Symbol: RTALB

Financial Performance

In 2025, IST:RTALB's revenue was 239.56 million, an increase of 15.41% compared to the previous year's 207.58 million. Earnings were 881.18 million, an increase of 1188.81%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 17, 2026

Data Sources Report a data error